Title: A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis (LUCENT-ACT)
Associated condition: Colorectal Cancer/ Colonoscopy
Status: Currently enrolling
Brief summary: The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer.
Primary objectives:
- Sensitivity of colorectal cancer detection
- Specificity of advanced neoplasia detection
Estimated length of study: It is estimated that the study be fully completed by January 2024.
